FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Heilig

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Activities & Behaviors

Anatomy

Procedures

Geographic Areas

Sweden

Concepts & Ideas

Co-author Network

Publications

TOP 3
Estelle Barbier; Kejun Cheng; Scott Edwards; Nathan Juergens; George F Koob; Kaushik K Misra; Paula E Park; Kenner C Rice; Jesse Schank; Joel E Schlosburg; Gery Schulteis; Leandro F Vendruscolo; Markus Heilig
The NK1 receptor antagonist l822429 reduces heroin reinforcement.
Jesse R Schank; Matthew G Solomon; Hui Sun; Jenica D Tapocik; Mengdi Yao; Estelle Barbier; Kejun Cheng; Ruslan Damadzic; Robert L Eskay; Meghan E Flanigan; Camilla Karlsson; Courtney E King; Kenner C Rice; Kelly E Rowe; Markus Heilig
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
Melissa A Herman; Marsida Kallupi; George F Koob; George Luu; Christopher S Oleata; Roberto Ciccocioppo; Markus Heilig; Marisa Roberto
Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: Alcohol and CRF effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Heilig (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Estelle Barbier; Kejun Cheng; Scott Edwards; Nathan Juergens; George F Koob; Kaushik K Misra; Paula E Park; Kenner C Rice; Jesse Schank; Joel E Schlosburg; Gery Schulteis; Leandro F Vendruscolo; Markus Heilig
The NK1 receptor antagonist l822429 reduces heroin reinforcement.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(6):976-84.
2013: Jesse R Schank; Matthew G Solomon; Hui Sun; Jenica D Tapocik; Mengdi Yao; Estelle Barbier; Kejun Cheng; Ruslan Damadzic; Robert L Eskay; Meghan E Flanigan; Camilla Karlsson; Courtney E King; Kenner C Rice; Kelly E Rowe; Markus Heilig
Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
Biological psychiatry 2013;73(8):774-81.
2013: Melissa A Herman; Marsida Kallupi; George F Koob; George Luu; Christopher S Oleata; Roberto Ciccocioppo; Markus Heilig; Marisa Roberto
Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: Alcohol and CRF effects.
Neuropharmacology 2013;67():337-48.
2013: Eric P Zorrilla; Harriet de Wit; Markus Heilig; Yavin Shaham
Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.
Drug and alcohol dependence 2013;128(3):175-86.
2013: Sharon L Walsh; Paul A Nuzzo; Markus Heilig; Pam Henderson; Michelle R Lofwall
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Addiction biology 2013;18(2):332-43.
2013: Lydia O Ayanwuyi; K Björk; Francisca Carvajal; Roberto Ciccocioppo; Esi Domi; Markus Heilig; Jose M Lerma-Cabrera; Marisa Roberto; Massimo Ubaldi; Andrea Cippitelli
Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats.
Frontiers in psychiatry / Frontiers Research Foundation 2013;4():23.
2013: John C Umhau; Robert J Ursano; David T George; Robert P Heaney; Markus Heilig; Joseph R Hibbeln; Michael D Lewis; Melanie L Schwandt
Low vitamin D status and suicide: a case-control study of active duty military service members.
PloS one 2013;8(1):e51543.
2012: Jesse R Schank; Andrey E Ryabinin; Roberto Ciccocioppo; William J Giardino; Markus Heilig
Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.
Neuron 2012;76(1):192-208.
2012: Camilla Karlsson; Annika Thorsell; Michelle Zook; Roberto Ciccocioppo; Donald R Gehlert; Markus Heilig; Andrea Cippitelli
Melanin-concentrating hormone receptor 1 (MCH1-R) antagonism: reduced appetite for calories and suppression of addictive-like behaviors.
Pharmacology, biochemistry, and behavior 2012;102(3):400-6.
2012: Rose-Marie Karlsson; David M Lovinger; Anna Molander; Stephanie Perreau-Lenz; Erick Singley; Matthew Solomon; Rainer Spanagel; Kohichi Tanaka; Louise Adermark; Andrew Holmes; Markus Heilig
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST.
Neuropharmacology 2012;63(2):181-9.
2012: Ming-Chyi Huang; Vijay A Ramchandani; Melanie L Schwandt; David T George; Markus Heilig
Impact of multiple types of childhood trauma exposure on risk of psychiatric comorbidity among alcoholic inpatients.
Alcoholism, clinical and experimental research 2012;36(6):1099-107.
2012: Jesse R Schank; Annika Thorsell; Jenny L Wiley; F Ivy Carroll; Andrea L Goldstein; Courtney E King; Julie A Marusich; Kelly E Rowe; Markus Heilig
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
Addiction biology 2012;17(3):634-47.
2012: Raye Z Litten; Howard B Moss; Megan L Ryan; Changhai Cui; Mark Egli; Daniel E Falk; Joanne Fertig; Markus Heilig; Robert Huebner; Antonio Noronha
Medications development to treat alcohol dependence: a vision for the next decade.
Addiction biology 2012;17(3):513-27.
2012: Chun-Hsin Chen; Markus Heilig; Reza Momenan; Robert Rawlings; Jonathan Walker; Daniel W Hommer
Relationship between liver function and brain shrinkage in patients with alcohol dependence.
Alcoholism, clinical and experimental research 2012;36(4):625-32.
2012: Anna Molander; Jan M Deussing; Markus Heilig; Valentina Vengeliene; Wolfgang Wurst; Rainer Spanagel
Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(4):1047-56.
2012: Simona Spinelli; Stephen J Suomi; David Goldman; Markus Heilig; J Dee Higley; Stephen G Lindell; Melanie L Schwandt; Christina S Barr
The serotonin transporter gene linked polymorphic region is associated with the behavioral response to repeated stress exposure in infant rhesus macaques.
Development and psychopathology 2012;24(1):157-65.
2012: Lawrence D Snell; Boris Tabakoff; David T George; Markus Heilig; Anders Helander; David Herion; Paula L Hoffman; Monte J Phillips; Lutz Pridzun; Vijay A Ramchandani; Laura Saba; Melanie L Schwandt
The biometric measurement of alcohol consumption.
Alcoholism, clinical and experimental research 2012;36(2):332-41.
2011: Smitha Sreedharan; Olga Stephansson; Wolfgang Sommer; Markus Almén; Valeria P Carlini; Susana R de Barioglio; Robert Fredriksson; Tatjana Haitina; Markus Heilig; Helgi B Schiöth
The G protein coupled receptor Gpr153 shares common evolutionary origin with Gpr162 and is highly expressed in central regions including the thalamus, cerebellum and the arcuate nucleus.
The FEBS journal 2011;278(24):4881-94.
2011: Markus Heilig; Wade Berrettini; David Goldman; Charles P O'Brien
Pharmacogenetic approaches to the treatment of alcohol addiction.
Nature reviews. Neuroscience 2011;12(11):670-84.
2011: Saifeldin Mahmoud; Selena E Bartlett; Markus Heilig; Joan K Holgate; Wolfgang Sommer; Annika Thorsell; Victor Ruiz-Velasco
Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.
Anesthesiology 2011;115(5):1054-62.
2011: Jesse R Schank; Yavin Shaham; Annika Thorsell; Kejun Cheng; Charles L Pickens; Kenner C Rice; Kelly E Rowe; Markus Heilig
Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.
Psychopharmacology 2011;218(1):111-9.
2011: Melanie L Schwandt; Stephen J Suomi; Markus Heilig; James D Higley; Stephen G Lindell; Christina S Barr
OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.
Psychoneuroendocrinology 2011;36(9):1303-11.
2011: Anita C Hansson; Markus Heilig; Aleksander A Mathé; Roberto Rimondini; Wolfgang Sommer
Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats.
Journal of psychopharmacology (Oxford, England) 2011;25(10):1378-87.
2011: Andrea Cippitelli; Lindsay Eisenberg; Markus Heilig; Edward D Levin; Timothy W Lovenberg; S Timothy Motley; Amir H Rezvani; J Elliott Robinson; Pascal Bonaventure; Annika Thorsell
The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
Alcohol (Fayetteville, N.Y.) 2011;45(6):567-76.
2011: Vijay A Ramchandani; Victor Ruiz-Velasco; M Schoor; Melanie L Schwandt; Wolfgang Sommer; H Sun; Annika Thorsell; J Umhau; Ruslan Damadzic; R Eskay; David T George; Peter Herscovitch; Daniel W Hommer; Wojciech Margas; L H Parsons; F J Pavon; Markus Heilig
A genetic determinant of the striatal dopamine response to alcohol in men.
Molecular psychiatry 2011;16(8):809-17.
2011: Markus Heilig; Kenneth R Warren; George Kunos; Peter B Silverman; Brenda G Hewitt
Addiction research centres and the nurturing of creativity: the National Institute on Alcohol Abuse and Alcoholism.
Addiction (Abingdon, England) 2011;106(6):1052-60.
2011: Markus Heilig
A welcome change that stops short of being fully satisfying.
Addiction (Abingdon, England) 2011;106(5):874-5; discussion 895-7.
2011: John C Umhau; Melanie L Schwandt; Julie Usala; Christopher Geyer; Erick Singley; David T George; Markus Heilig
Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(6):1178-86.
2011: Serena Stopponi; Lorenzo Somaini; Andrea Cippitelli; Nazzareno Cannella; Simone Braconi; Marsida Kallupi; Barbara Ruggeri; Markus Heilig; Gregory Demopulos; George Gaitanaris; Maurizio Massi; Roberto Ciccocioppo
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking.
Biological psychiatry 2011;69(7):642-9.
2010: Marsida Kallupi; Nazzareno Cannella; Daina Economidou; Massimo Ubaldi; Barbara Ruggeri; Friedbert Weiss; Maurizio Massi; Juan Marugan; Markus Heilig; Patricia Bonnavion; Luis de Lecea; Roberto Ciccocioppo
Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(45):19567-72.
2010: Andrea Cippitelli; Michelle Zook; Lauren Bell; Ruslan Damadzic; Robert L Eskay; Melanie Schwandt; Markus Heilig
Reversibility of object recognition but not spatial memory impairment following binge-like alcohol exposure in rats.
Neurobiology of learning and memory 2010;94(4):538-46.
2010: Markus Heilig; Annika Thorsell; Wolfgang Sommer; Anita C Hansson; Vijay A Ramchandani; David T George; Daniel W Hommer; Christina S Barr
Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
Neuroscience and biobehavioral reviews 2010;35(2):334-44.
2010: John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel W Hommer; Markus Heilig
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
Archives of general psychiatry 2010;67(10):1069-77.
2010: Andrea Cippitelli; Camilla Karlsson; Janice L Shaw; Annika Thorsell; Donald R Gehlert; Markus Heilig
Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats.
Psychopharmacology 2010;211(4):367-75.
2010: Wolfgang Sommer; Jessica Lidström; Hui Sun; Derek Passer; Robert Eskay; Stephen C J Parker; Stephanie Witt; Ulrich S Zimmermann; Vanessa Nieratschker; Marcella Rietschel; Elliott H Margulies; Miklós Palkovits; Manfred Laucht; Markus Heilig
Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect.
Human mutation 2010;31(8):E1594-608.
2010: K Björk; Anton Terasmaa; Hui Sun; Annika Thorsell; Wolfgang Sommer; Markus Heilig
Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors.
Addiction biology 2010;15(3):299-303.
2010: Simona Spinelli; Svetlana Chefer; Richard E Carson; Elaine Jagoda; Lixin Lang; Markus Heilig; Christina S Barr; Stephen J Suomi; J Dee Higley; Elliot A Stein
Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography.
Biological psychiatry 2010;67(12):1146-53.
2010: Anita C Hansson; Kimberly Nixon; Roberto Rimondini; Ruslan Damadzic; Wolfgang Sommer; Robert Eskay; Fulton T Crews; Markus Heilig
Long-term suppression of forebrain neurogenesis and loss of neuronal progenitor cells following prolonged alcohol dependence in rats.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010;13(5):583-93.
2010: Andrea Cippitelli; Ruslan Damadzic; Kate Frankola; Andrea Goldstein; Annika Thorsell; Erick Singley; Robert L Eskay; Markus Heilig
Alcohol-induced neurodegeneration, suppression of transforming growth factor-beta, and cognitive impairment in rats: prevention by group II metabotropic glutamate receptor activation.
Biological psychiatry 2010;67(9):823-30.
2010: Markus Heilig; Mark Egli; John C Crabbe; Howard C Becker
Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Addiction biology 2010;15(2):169-84.
2010: Asa Magnusson; Mona Göransson; Markus Heilig
Early onset alcohol dependence with high density of family history is not "male limited".
Alcohol (Fayetteville, N.Y.) 2010;44(2):131-9.
2010: Melanie L Schwandt; Stephen G Lindell; Rickard L Sjöberg; Kelli L Chisholm; J Dee Higley; Stephen J Suomi; Markus Heilig; Christina S Barr
Gene-environment interactions and response to social intrusion in male and female rhesus macaques.
Biological psychiatry 2010;67(4):323-30.
2010: Melanie L Schwandt; Stephen G Lindell; Scott Chen; J Dee Higley; Stephen J Suomi; Markus Heilig; Christina S Barr
Alcohol response and consumption in adolescent rhesus macaques: life history and genetic influences.
Alcohol (Fayetteville, N.Y.) 2010;44(1):67-80.
2010: Andrea Cippitelli; Ruslan Damadzic; Anita C Hansson; Erick Singley; Wolfgang Sommer; Robert Eskay; Annika Thorsell; Markus Heilig
Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking.
Psychopharmacology 2010;208(3):417-26.
2010: David T George; David W Herion; Cheryl L Jones; Monte J Phillips; Jacqueline Hersh; Debra Hill; Markus Heilig; Vijay A Ramchandani; Christopher Geyer; David E Spero; Erick D Singley; Stephanie S O'Malley; Raafat Bishai; Robert R Rawlings; George Kunos
Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers.
Psychopharmacology 2010;208(1):37-44.
2010: Christina S Barr; Scott A Chen; Melanie L Schwandt; Stephen G Lindell; Hui Sun; Stephen J Suomi; Markus Heilig
Suppression of alcohol preference by naltrexone in the rhesus macaque: a critical role of genetic variation at the micro-opioid receptor gene locus.
Biological psychiatry 2010;67(1):78-80.
2009: Roberto Ciccocioppo; Donald R Gehlert; Andrey E Ryabinin; Simranjit Kaur; Andrea Cippitelli; Annika Thorsell; Anh Dzung Lê; Philip A Hipskind; Chafiq Hamdouchi; Jianliang Lu; Erik J Hembre; Jeffrey Cramer; Min Song; David McKinzie; Michelle Morin; Daina Economidou; Serena Stopponi; Nazzareno Cannella; Simone Braconi; Marsida Kallupi; Giordano de Guglielmo; Maurizio Massi; David T George; Jody Gilman; Jacqueline Hersh; Johannes T Tauscher; Stephen P Hunt; Daniel Hommer; Markus Heilig
Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
Alcohol (Fayetteville, N.Y.) 2009;43(7):491-8.
2009: Christina S Barr; Rachel L Dvoskin; Manisha Gupte; Wolfgang Sommer; Hui Sun; Melanie L Schwandt; Stephen G Lindell; John W Kasckow; Stephen J Suomi; David Goldman; J Dee Higley; Markus Heilig
Functional CRH variation increases stress-induced alcohol consumption in primates.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(34):14593-8.
2009: Nazzareno Cannella; Daina Economidou; Marsida Kallupi; Serena Stopponi; Markus Heilig; Maurizio Massi; Roberto Ciccocioppo
Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(9):2125-34.
2009: Elisabet Jerlhag; Emil Egecioglu; Sara Landgren; Nicolas Salomé; Markus Heilig; Diederik Moechars; Rakesh Datta; Daniel Perrissoud; Suzanne Dickson; Jörgen A Engel
Requirement of central ghrelin signaling for alcohol reward.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(27):11318-23.
2009: Mette Skinbjerg; Marjorie A Ariano; Annika Thorsell; Markus Heilig; Christer Halldin; Robert B Innis; David R Sibley
Arrestin3 mediates D(2) dopamine receptor internalization.
Synapse (New York, N.Y.) 2009;63(7):621-4.
2009: Rose M Karlsson; Kohichi Tanaka; Lisa M Saksida; Timothy J Bussey; Markus Heilig; Andrew Holmes
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(6):1578-89.
2009: Kristina Wahlberg; Per Hamid Ghatan; Sieglinde Modell; Ake Nygren; Martin Ingvar; Marie Asberg; Markus Heilig
Suppressed neuroendocrine stress response in depressed women on job-stress-related long-term sick leave: a stable marker potentially suggestive of preexisting vulnerability.
Biological psychiatry 2009;65(9):742-7.
2009: Olga Neznanova; K Björk; Roberto Rimondini; Anita C Hansson; Petri Hyytiä; Markus Heilig; Wolfgang Sommer
Acute ethanol challenge inhibits glycogen synthase kinase-3beta in the rat prefrontal cortex.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):275-80.
2008: Rose M Karlsson; Kohichi Tanaka; Markus Heilig; Andrew Holmes
Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.
Biological psychiatry 2008;64(9):810-4.
2008: Markus Heilig; Lars Gunne
[New guidelines against unfair treatment of narcotic addicts necessary].
Läkartidningen 2008;105(44):3093-4.
2008: Christina S Barr; Rachel L Dvoskin; Qiaoping Yuan; Robert H Lipsky; Manisha Gupte; Xian Hu; Zhifeng Zhou; Melanie L Schwandt; Stephen G Lindell; Megan McKee; Michelle L Becker; Mitchel A Kling; Phillip W Gold; Dee Higley; Markus Heilig; Stephen J Suomi; David Goldman
CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.
Archives of general psychiatry 2008;65(8):934-44.
2008: Daina Economidou; Anita C Hansson; Friedbert Weiss; Anton Terasmaa; Wolfgang Sommer; Andrea Cippitelli; Amalia Fedeli; Rèmi Martin-Fardon; Maurizio Massi; Roberto Ciccocioppo; Markus Heilig
Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.
Biological psychiatry 2008;64(3):211-8.
2008: Melanie L Schwandt; J Dee Higley; Stephen J Suomi; Markus Heilig; Christina S Barr
Rapid tolerance and locomotor sensitization in ethanol-naïve adolescent rhesus macaques.
Alcoholism, clinical and experimental research 2008;32(7):1217-28.
2008: K Björk; Roberto Rimondini; Anita C Hansson; A Terasmaa; Petri Hyytiä; Markus Heilig; Wolfgang Sommer
Modulation of voluntary ethanol consumption by beta-arrestin 2.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2552-60.
2008: Johan Kakko; Markus Heilig; Ihsan Sarman
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Drug and alcohol dependence 2008;96(1-2):69-78.
2008: Anita C Hansson; Roberto Rimondini; Olga Neznanova; Wolfgang Sommer; Markus Heilig
Neuroplasticity in brain reward circuitry following a history of ethanol dependence.
The European journal of neuroscience 2008;27(8):1912-22.
2008: Christina S Barr; Melanie L Schwandt; Stephen G Lindell; J Dee Higley; Dario Maestripieri; David Goldman; Stephen J Suomi; Markus Heilig
Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(13):5277-81.
2008: David T George; Jodi Gilman; Jacqueline Hersh; Annika Thorsell; David Herion; Christopher Geyer; Xiaomei Peng; William Kielbasa; Robert R Rawlings; John E Brandt; Donald R Gehlert; Johannes T Tauscher; Stephen P Hunt; Daniel W Hommer; Markus Heilig
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
Science (New York, N.Y.) 2008;319(5869):1536-9.
2008: Jia Huang; Brandon Young; Mathew Pletcher; Markus Heilig; Claes Wahlestedt
Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence.
Addiction biology 2008;13(1):88-94.
2008: Roberto Rimondini; Wolfgang Sommer; Rossella Dall'Olio; Markus Heilig
Long-lasting tolerance to alcohol following a history of dependence.
Addiction biology 2008;13(1):26-30.
2008: Johan Kakko; Joachim von Wachenfeldt; Kerstin Dybrandt Svanborg; Jessica Lidström; Christina S Barr; Markus Heilig
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Biological psychiatry 2008;63(2):172-7.
2008: Wolfgang Sommer; Roberto Rimondini; Anita C Hansson; Philip A Hipskind; Donald R Gehlert; Christina S Barr; Markus Heilig
Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence.
Biological psychiatry 2008;63(2):139-45.
2008: Rose M Karlsson; Jessica S Choe; Heather A Cameron; Annika Thorsell; Jacqueline N Crawley; Andrew Holmes; Markus Heilig
The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
Psychopharmacology 2008;195(4):547-57.
2007: Markus Heilig
Imagen: implications for addiction science and science policy.
Addiction (Abingdon, England) 2007;102(11):1699-700.
2007: Anna Björkdahl; Markus Heilig; Tom Palmstierna; Görel Hansebo
Changes in the occurrences of coercive interventions and staff injuries on a psychiatric intensive care unit.
Archives of psychiatric nursing 2007;21(5):270-7.
2007: Wolfgang Sommer; Roberto Rimondini; M Marquitz; J Lidström; W-E Siems; M Bader; Markus Heilig
Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence.
Journal of molecular medicine (Berlin, Germany) 2007;85(10):1089-97.
2007: Markus Heilig; George F Koob
A key role for corticotropin-releasing factor in alcohol dependence.
Trends in neurosciences 2007;30(8):399-406.
2007: Annika Thorsell; Justin Johnson; Markus Heilig
Effect of the adenosine A2a receptor antagonist 3,7-dimethyl-propargylxanthine on anxiety-like and depression-like behavior and alcohol consumption in Wistar Rats.
Alcoholism, clinical and experimental research 2007;31(8):1302-7.
2007: Asa Magnusson; Mona Göransson; Markus Heilig
Hazardous alcohol users during pregnancy: psychiatric health and personality traits.
Drug and alcohol dependence 2007;89(2-3):275-81.
2007: Johan Kakko; Leif Grönbladh; Kerstin Dybrandt Svanborg; Joachim von Wachenfeldt; Christian Rück; Bob Rawlings; Lars-Håkan Nilsson; Markus Heilig
A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
The American journal of psychiatry 2007;164(5):797-803.
2007: Donald R Gehlert; Andrea Cippitelli; Annika Thorsell; Anh Dzung Lê; Philip A Hipskind; Chafiq Hamdouchi; Jianliang Lu; Erik J Hembre; Jeffrey Cramer; Min Song; David L McKinzie; Michelle Morin; Roberto Ciccocioppo; Markus Heilig
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(10):2718-26.
2007: Anita C Hansson; Andrea Cippitelli; Wolfgang Sommer; Roberto Ciccocioppo; Markus Heilig
Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol.
Addiction biology 2007;12(1):30-4.
2007: Christina S Barr; Melanie L Schwandt; Stephen G Lindell; Scott A Chen; David Goldman; Stephen J Suomi; J Dee Higley; Markus Heilig
Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques.
Archives of general psychiatry 2007;64(3):369-76.
2007: Simona Spinelli; Melanie L Schwandt; Stephen G Lindell; Timothy K Newman; Markus Heilig; Stephen J Suomi; J Dee Higley; David Goldman; Christina S Barr
Association between the recombinant human serotonin transporter linked promoter region polymorphism and behavior in rhesus macaques during a separation paradigm.
Development and psychopathology 2007;19(4):977-87.
2007: Roberto Ciccocioppo; Daina Economidou; Roberto Rimondini; Wolfgang Sommer; Maurizio Massi; Markus Heilig
Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.
Biological psychiatry 2007;61(1):4-12.
2007: Anita C Hansson; Francisco Javier Bermúdez-Silva; Hanna Malinen; Petri Hyytiä; Irene Sanchez-Vera; Roberto Rimondini; Fernando Rodriguez de Fonseca; George Kunos; Wolfgang Sommer; Markus Heilig
Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):117-26.
2006: Ingrid Rydmark; Kristina Wahlberg; Per Hamid Ghatan; Sieglinde Modell; Ake Nygren; Martin Ingvar; Marie Asberg; Markus Heilig
Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression.
Biological psychiatry 2006;60(8):867-73.
2006: Anita C Hansson; Andrea Cippitelli; Wolfgang Sommer; Amalia Fedeli; K Björk; Laura Soverchia; A Terasmaa; Maurizio Massi; Markus Heilig; Roberto Ciccocioppo
Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(41):15236-41.
2006: K Björk; Sirkku Saarikoski; Christina Arlinde; L Kovanen; D Osei-Hyiaman; M Ubaldi; Mark Reimers; Petri Hyytiä; Markus Heilig; Wolfgang Sommer
Glutathione-S-transferase expression in the brain: possible role in ethanol preference and longevity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(11):1826-35.
2006: Markus Heilig; Mark Egli
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Pharmacology & therapeutics 2006;111(3):855-76.
2006: Mona Göransson; Asa Magnusson; Markus Heilig
Identifying hazardous alcohol consumption during pregnancy: implementing a research-based model in real life.
Acta obstetricia et gynecologica Scandinavica 2006;85(6):657-62.
2006: Annika Thorsell; Rose M Karlsson; Markus Heilig
NPY in alcoholism and psychiatric disorders.
EXS 2006;(95):183-92.
2005: Rainer Spanagel; Markus Heilig
Addiction and its brain science.
Addiction (Abingdon, England) 2005;100(12):1813-22.
2005: Mark Reimers; Markus Heilig; Wolfgang Sommer
Gene discovery in neuropharmacological and behavioral studies using Affymetrix microarray data.
Methods (San Diego, Calif.) 2005;37(3):219-28.
2005: Salim Mottagui-Tabar; Jonathan A Prince; Claes Wahlestedt; Guanshan Zhu; David Goldman; Markus Heilig
A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence.
Alcoholism, clinical and experimental research 2005;29(5):702-7.
2005: Andrea Cippitelli; Ainhoa Bilbao; Anita C Hansson; Ignacio Del Arco; Wolfgang Sommer; Markus Heilig; Maurizio Massi; Francisco Javier Bermúdez-Silva; Miguel Navarro; Roberto Ciccocioppo; Fernando Rodríguez de Fonseca
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
The European journal of neuroscience 2005;21(8):2243-51.
2005: Asa Magnusson; Mona Göransson; Markus Heilig
Unexpectedly high prevalence of alcohol use among pregnant Swedish women: failed detection by antenatal care and simple tools that improve detection.
Journal of studies on alcohol 2005;66(2):157-64.
2005: Wolfgang Sommer; Christina Arlinde; Markus Heilig
The search for candidate genes of alcoholism: evidence from expression profiling studies.
Addiction biology 2005;10(1):71-9.
2005: Rose M Karlsson; Andrew Holmes; Markus Heilig; Jacqueline N Crawley
Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.
Pharmacology, biochemistry, and behavior 2005;80(3):427-36.
2005: Roberto Rimondini; Annika Thorsell; Markus Heilig
Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Neuroscience letters 2005;375(2):129-33.
2005: Gavin Bart; Mary Jeanne Kreek; Jurg Ott; K Steven LaForge; Dmitri Proudnikov; Lotta Pollak; Markus Heilig
Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(2):417-22.
2004: Raffael Kalisch; Nicolas Salomé; Stefan Platzer; Alexandra Wigger; Michael Czisch; Wolfgang Sommer; Nicolas Singewald; Markus Heilig; Achim Berthele; Florian Holsboer; Rainer Landgraf; Dorothee P Auer
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats.
NeuroImage 2004;23(1):382-91.
2004: Mona Göransson; Elisabeth Faxelid; Markus Heilig
Beliefs and reality: detection and prevention of high alcohol consumption in Swedish antenatal clinics.
Acta obstetricia et gynecologica Scandinavica 2004;83(9):796-800.
2004: Salim Mottagui-Tabar; Shane McCarthy; Jana Reinemund; Björn Andersson; Claes Wahlestedt; Markus Heilig
Analysis of 5-hydroxytryptamine 2c receptor gene promoter variants as alcohol-dependence risk factors.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(5):380-5.
2004: Markus Heilig
The NPY system in stress, anxiety and depression.
Neuropeptides 2004;38(4):213-24.
2004: Gavin Bart; Markus Heilig; K Steven LaForge; L Pollak; S M Leal; Jurg Ott; Mary Jeanne Kreek
Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.
Molecular psychiatry 2004;9(6):547-9.
2004: Markus Heilig; Olof Zachrisson; Annika Thorsell; Anna Ehnvall; Salim Mottagui-Tabar; Magnus Sjögren; Marie Asberg; Rolf Ekman; Claes Wahlestedt; Hans Agren
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
Journal of psychiatric research 2004;38(2):113-21.
2004: Roberto Ciccocioppo; Daina Economidou; Amalia Fedeli; Stefania Angeletti; Friedbert Weiss; Markus Heilig; Maurizio Massi
Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.
Psychopharmacology 2004;172(2):170-8.
2004: Markus Heilig; Wolfgang Sommer
Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence.
Neurotoxicity research 2004;6(5):363-72.
2004: Christina Arlinde; Wolfgang Sommer; K Björk; Mark Reimers; Petri Hyytiä; Kalervo Kiianmaa; Markus Heilig
A cluster of differentially expressed signal transduction genes identified by microarray analysis in a rat genetic model of alcoholism.
The pharmacogenomics journal 2004;4(3):208-18.
2004: Laura Caberlotto; Roberto Rimondini; Anita C Hansson; Siv Eriksson; Markus Heilig
Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(1):15-22.
2003: Mona Göransson; Asa Magnusson; Hans Bergman; Ulf Rydberg; Markus Heilig
Fetus at risk: prevalence of alcohol consumption during pregnancy estimated with a simple screening method in Swedish antenatal clinics.
Addiction (Abingdon, England) 2003;98(11):1513-20.
2003: Andrew Holmes; Markus Heilig; Nadia M J Rupniak; Thomas Steckler; Guy Griebel
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.
Trends in pharmacological sciences 2003;24(11):580-8.
2003: Markus Heilig; Johan Kakko
[Reduced drug craving and better social function with buprenorphine therapy. Combination therapy as an alternative to methadone therapy in heroin addiction].
Läkartidningen 2003;100(32-33):2526-7.
2003: Johanna Kela; Peter Salmi; Roberto Rimondini-Giorgini; Markus Heilig; Claes Wahlestedt
Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties.
Regulatory peptides 2003;114(2-3):109-14.
2003: Roberto Rimondini; Wolfgang Sommer; Markus Heilig
A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication.
Journal of studies on alcohol 2003;64(4):445-9.
2003: Roberto Rimondini; Greta Agren; Sofia Börjesson; Wolfgang Sommer; Markus Heilig
Persistent behavioral and autonomic supersensitivity to stress following prenatal stress exposure in rats.
Behavioural brain research 2003;140(1-2):75-80.
2003: Markus Heilig
[Ecstasy is a dangerous drug the society chooses to ignore].
Läkartidningen 2003;100(9):688-90.
2003: Johan Kakko; Kerstin Dybrandt Svanborg; Mary Jeanne Kreek; Markus Heilig
1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.
Lancet 2003;361(9358):662-8.
2003: Rolf Adolfsson; Susanne Bejerot; Jörgen Engel; Hans Forssberg; Markus Heilig; Mats Humble; Martin Ingvar; Sten Levander; Lars Oreland; Nancy Pedersen; Marie Asberg; Arne Ohman
[Researchers and psychiatrists defending Gillberg's research on ADDH: Karfve's campaign is a form of personal persecution and scientific basis is missing].
Läkartidningen 2003;100(8):636-7.
2003: Subhash C Pandey; Lucinda G Carr; Markus Heilig; Erkki Ilveskoski; Todd E Thiele
Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence.
Alcoholism, clinical and experimental research 2003;27(2):149-54.
2003: Guanshan Zhu; Lotta Pollak; Salim Mottagui-Tabar; Claes Wahlestedt; Julie Taubman; Matti Virkkunen; David Goldman; Markus Heilig
NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations.
Alcoholism, clinical and experimental research 2003;27(1):19-24.
2002: Annika Thorsell; Roberto Rimondini; Markus Heilig
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats.
Neuroscience letters 2002;332(1):1-4.
2002: Markus Heilig; Kaj Forslund; Marie Asberg; Ulf Rydberg
The dual-diagnosis concept used by Swedish social workers: limited validity upon examination using a structured diagnostic approach.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17(6):363-5.
2002: Markus Heilig; Lars Oreland; Rolf Ekman; Torbjörn Akerstedt; Ake Nygren
[The brain behind stress and fatigue depression].
Läkartidningen 2002;99(22):2515-8.
2002: Annika Thorsell; Markus Heilig
Diverse functions of neuropeptide Y revealed using genetically modified animals.
Neuropeptides 2002;36(2-3):182-93.
2002: Annika Thorsell; Laura Caberlotto; Roberto Rimondini; Markus Heilig
Leptin suppression of hypothalamic NPY expression and feeding, but not amygdala NPY expression and experimental anxiety.
Pharmacology, biochemistry, and behavior 2002;71(3):425-30.
2002: Markus Heilig
[Documented effect of methadone, but not naltrexone].
Läkartidningen 2002;99(6):551-2.
2002: Markus Heilig
[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
Läkartidningen 2002;99(3):200-4.
2002: Markus Heilig; Annika Thorsell
Brain neuropeptide Y (NPY) in stress and alcohol dependence.
Reviews in the neurosciences 2002;13(1):85-94.
2002: Roberto Rimondini; Wolfgang Sommer; Markus Heilig
Effects of tiagabine and diazepam on operant ethanol self-administration in the rat.
Journal of studies on alcohol 2002;63(1):100-6.
2002: Christian Möller; Wolfgang Sommer; Annika Thorsell; Roberto Rimondini; Markus Heilig
Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):119-22.
2002: Roberto Rimondini; Christina Arlinde; Wolfgang Sommer; Markus Heilig
Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(1):27-35.
2001: Laura Caberlotto; Annika Thorsell; Roberto Rimondini; Wolfgang Sommer; Petri Hyytiä; Markus Heilig
Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats.
Alcoholism, clinical and experimental research 2001;25(11):1564-9.
2001: Markus Heilig; Lars-Håkan Nilsson; Leif Grönbladh; S O Thulin; B Sternebring
[Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
Läkartidningen 2001;98(37):3956-8.
2001: Markus Heilig
[A welcomed SBU report shows efficient methods against abuse. But certain parts are already out of date].
Läkartidningen 2001;98(37):3903-4.
2001: Annika Thorsell; Susanne H M Gruber; Aleksander A Mathé; Markus Heilig
Neuropeptide Y (NPY) mRNA in rat brain tissue: effects of decapitation and high-energy microwave irradiation on post mortem stability.
Neuropeptides 2001;35(3-4):168-73.
2001: M Smiałowska; M Bajkowska; Markus Heilig; Ewa Obuchowicz; Jadwiga Turchan; M Maj; R Przewłocki
Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
Neuropeptides 2001;35(2):82-91.
2001: Wolfgang Sommer; C Möller; L Wiklund; Annika Thorsell; Roberto Rimondini; Hans Nissbrandt; Markus Heilig
Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(4):430-40.
2001: Wolfgang Sommer; Christina Arlinde; Laura Caberlotto; Annika Thorsell; P Hyytia; Markus Heilig
Differential expression of diacylglycerol kinase iota and L18A mRNAs in the brains of alcohol-preferring AA and alcohol-avoiding ANA rats.
Molecular psychiatry 2001;6(1):103-8; 5.
2000: Annika Thorsell; M Michalkiewicz; Yvan Dumont; R Quirion; Laura Caberlotto; Roberto Rimondini; Aleksander A Mathé; Markus Heilig
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(23):12852-7.
2000: Mauro Santos; C Coutelle; Anna Rosell; F Fernández-Muixi; Montserrat Broch; Bernat Crosas; L Hjelmqvist; A Lorenzo; C Gutiérrez; Martín Santos; M Szczepanek; Markus Heilig; P Quattrocchi; Jaume Farrés; Francesc Vidal; Cristóbal Richart; T Mach; J Bogdal; Hans Jörnvall; Helmut K Seitz; P Couzigou; Xavier Parés
Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1.
Hepatology (Baltimore, Md.) 2000;31(4):984-9.
2000: Kaj Blennow; N Bogdanovic; Markus Heilig; B Grenfeldt; Ingvar Karlsson; Pia Davidsson
Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(8-9):1085-97.
2000: Wolfgang Sommer; M O Hebb; Markus Heilig
Pharmacokinetic properties of oligonucleotides in brain.
Methods in enzymology 2000;314():261-75.
1999: Markus Heilig
[Re-establishing the medical culture in psychiatry!].
Läkartidningen 1999;96(41):4427-8, 4431-3.
1999: C Möller; Wolfgang Sommer; Annika Thorsell; Markus Heilig
Anxiogenic-like action of galanin after intra-amygdala administration in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(4):507-12.
1999: Annika Thorsell; K Carlsson; R Ekman; Markus Heilig
Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress.
Neuroreport 1999;10(14):3003-7.
1999: Annika Thorsell; E Fox; Markus Heilig
Lipid mediated gene delivery in the adult rat brain: quantitative analysis of expression.
Neurochemistry international 1999;35(1):65-71.
1999: Markus Heilig
[Substance dependence is easier to prevent than to treat. But is early identification of individuals at risk and aimed prevention ethically justified?].
Läkartidningen 1999;96(15):1796-801.
1999: Wolfgang Sommer; Markus Heilig
[Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes].
Läkartidningen 1999;96(4):348-54.
1998: O Bing; Markus Heilig; P Kakoulidis; Charlotta Sundblad; L Wiklund; Elias Eriksson
High doses of testosterone increase anticonflict behaviour in rat.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(4):321-3.
1998: Annika Thorsell; P Svensson; L Wiklund; Wolfgang Sommer; R Ekman; Markus Heilig
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress.
Regulatory peptides 1998;75-76():247-54.
1998: Agneta Ekman; Hans Nissbrandt; Markus Heilig; D Dijkstra; Elias Eriksson
Central administration of dopamine D3 receptor antisense to rat: effects on locomotion, dopamine release and [3H]spiperone binding.
Naunyn-Schmiedeberg's archives of pharmacology 1998;358(3):342-50.
1998: Markus Heilig
[Benzodiazepines are just a tool in the clinical work. Different opinions are both right and wrong].
Läkartidningen 1998;95(35):3628-9.
1998: Wolfgang Sommer; X Cui; B Erdmann; L Wiklund; G Bricca; Markus Heilig; Kjell Fuxe
The spread and uptake pattern of intracerebrally administered oligonucleotides in nerve and glial cell populations of the rat brain.
Antisense & nucleic acid drug development 1998;8(2):75-85.
1997: Per Svenningsson; J Georgieva; E Kontny; Markus Heilig; Bertil B. Fredholm
Involvement of a c-fos-dependent mechanism in caffeine-induced expression of the preprotachykinin A and neurotensin/neuromedin N genes in rat striatum.
The European journal of neuroscience 1997;9(10):2135-41.
1997: C Möller; L Wiklund; Wolfgang Sommer; Annika Thorsell; Markus Heilig
Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions.
Brain research 1997;760(1-2):94-101.
1997: C Möller; L Wiklund; Annika Thorsell; Petri Hyytiä; Markus Heilig
Decreased measures of experimental anxiety in rats bred for high alcohol preference.
Alcoholism, clinical and experimental research 1997;21(4):656-60.
1997: Markus Heilig
[When does alcohol trigger violence? "Emotional blindness" and impulsiveness are important links].
Läkartidningen 1997;94(10):841-4.
1997: Iqbal Grewal; Markus Heilig; A Miller; Eli E Sercarz
Environmental regulation of T-cell function in mice: group housing of males affects accessory cell function.
Immunology 1997;90(2):165-8.
1996: Kaj Blennow; P Davidsson; Carl-Gerhard Gottfries; R Ekman; Markus Heilig
Synaptic degeneration in thalamus in schizophrenia.
Lancet 1996;348(9028):692-3.
1996: David Erlinge; Markus Heilig; Lars Edvinsson
Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells.
British journal of pharmacology 1996;118(4):1028-34.
1996: Annika Thorsell; A G Blomqvist; Markus Heilig
Cationic lipid-mediated delivery and expression of prepro-neuropeptide Y cDNA after intraventricular administration in rat: feasibility and limitations.
Regulatory peptides 1996;61(3):205-11.
1996: Markus Heilig; J E Månsson; Kaj Blennow
Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
Biological psychiatry 1996;39(4):299-301.
1996: R Ekman; P Juhasz; Markus Heilig; Hans Agren; C E Costello
Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients.
Peptides 1996;17(7):1107-11.
1996: C Nilsson; G Karlsson; Kaj Blennow; Markus Heilig; R Ekman
Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients.
Peptides 1996;17(3):359-62.
1995: Carl-Gerhard Gottfries; S O Frederiksen; Markus Heilig
Neuropeptides and Alzheimer's disease.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(4):491-500.
1995: Markus Heilig
Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
Regulatory peptides 1995;59(2):201-5.
1995: Markus Heilig; Magnus Sjögren; Kaj Blennow; R Ekman; Anders Wallin
Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
Biological psychiatry 1995;38(4):210-6.
1995: O Bing; L Grundemar; L Ny; C Möller; Markus Heilig
Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin.
Neuroreport 1995;6(10):1369-72.
1995: Markus Heilig; R Ekman
Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH).
Neurochemistry international 1995;26(4):351-5.
1995: Hans Nissbrandt; Agneta Ekman; Elias Eriksson; Markus Heilig
Dopamine D3 receptor antisense influences dopamine synthesis in rat brain.
Neuroreport 1995;6(3):573-6.
1995: Markus Heilig; E Widerlöv
Neurobiology and clinical aspects of neuropeptide Y.
Critical reviews in neurobiology 1995;9(2-3):115-36.
1994: C Möller; O Bing; Markus Heilig
c-fos expression in the amygdala: in vivo antisense modulation and role in anxiety.
Cellular and molecular neurobiology 1994;14(5):415-23.
1994: Markus Heilig
[Neuropeptides affect emotional life. New discoveries on the function of the peptide system].
Läkartidningen 1994;91(26-27):2585-9.
1994: Markus Heilig; George F Koob; R Ekman; KT Britton
Corticotropin-releasing factor and neuropeptide Y: role in emotional integration.
Trends in neurosciences 1994;17(2):80-5.
1993: O Bing; C Möller; Jörgen A Engel; Bo Söderpalm; Markus Heilig
Anxiolytic-like action of centrally administered galanin.
Neuroscience letters 1993;164(1-2):17-20.
1993: E M Pich; George F Koob; Markus Heilig; F Menzaghi; Wylie Vale; Friedbert Weiss
Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis.
Neuroscience 1993;55(3):695-707.
1993: Markus Heilig; M Irwin; Iqbal Grewal; Eli E Sercarz
Sympathetic regulation of T-helper cell function.
Brain, behavior, and immunity 1993;7(2):154-63.
1993: Markus Heilig; S McLeod; M Brot; Stephen C Heinrichs; F Menzaghi; George F Koob; KT Britton
Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(4):357-63.
1993: Markus Heilig; Jörgen A Engel; Bo Söderpalm
C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine.
European journal of pharmacology 1993;236(2):339-40.
1993: Claes Wahlestedt; E M Pich; George F Koob; Frances Yee; Markus Heilig
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.
Science (New York, N.Y.) 1993;259(5094):528-31.
1992: Markus Heilig; S McLeod; George F Koob; KT Britton
Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test.
Regulatory peptides 1992;41(1):61-9.
1991: Markus Heilig; L Edvinsson; Claes Wahlestedt
Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
European journal of pharmacology 1991;209(1-2):27-32.
1990: Markus Heilig; E Widerlöv
Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses.
Acta psychiatrica Scandinavica 1990;82(2):95-114.
1990: Claes Wahlestedt; J A Blendy; Kenneth J Kellar; Markus Heilig; E Widerlöv; R Ekman
Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat.
Brain research 1990;507(1):65-8.
1990: Markus Heilig; L Vècséi; Claes Wahlestedt; Christer Alling; E Widerlöv
Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.
Journal of neural transmission. General section 1990;79(3):193-208.
1990: Claes Wahlestedt; L Grundemar; Rolf Håkanson; Markus Heilig; G H Shen; Z Zukowska-Grojec; Donald J Reis
Neuropeptide Y receptor subtypes, Y1 and Y2.
Annals of the New York Academy of Sciences 1990;611():7-26.
1989: Markus Heilig; L Vecsei; E Widerlöv
Opposite effects of centrally administered neuropeptide Y (NPY) on locomotor activity of spontaneously hypertensive (SH) and normal rats.
Acta physiologica Scandinavica 1989;137(2):243-8.
1989: L Vécsei; Christer Alling; Markus Heilig; E Widerlöv
Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats.
Pharmacology, biochemistry, and behavior 1989;32(3):629-35.
1989: Claes Wahlestedt; R Ekman; Markus Heilig; E Widerlöv
Effects of psychoactive drugs on delta sleep-inducing peptide concentrations in rat brain.
European journal of pharmacology 1989;159(3):285-9.
1989: Markus Heilig; Bo Söderpalm; Jörgen A Engel; E Widerlöv
Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models.
Psychopharmacology 1989;98(4):524-9.
1988: Markus Heilig; Claes Wahlestedt; E Widerlöv
Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors.
European journal of pharmacology 1988;157(2-3):205-13.
1988: Markus Heilig; Claes Wahlestedt; R Ekman; E Widerlöv
Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain.
European journal of pharmacology 1988;147(3):465-7.
1987: Markus Heilig; Robert Murison
Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat.
Regulatory peptides 1987;19(3-4):221-31.
1987: Claes Wahlestedt; G Skagerberg; R Ekman; Markus Heilig; F Sundler; R Håkanson
Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.
Brain research 1987;417(1):33-8.
1987: R Håkanson; B Beding; R Ekman; Markus Heilig; Claes Wahlestedt; F Sundler
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris.
Neuroscience 1987;21(3):943-50.
1987: Markus Heilig; Robert Murison
Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat.
European journal of pharmacology 1987;137(1):127-9.